Showing results (1-10 of 333) with videos related to
Sort By:
Pageof 34
Diabetes Research and Clinical Practice|May 1, 2007
Analysis of waist circumference in Japanese subjects with type 2 diabetes mellitus: lack of propriety to define the current criteria of metabolic syndromeYukiko Kanda, Masafumi Matsuda, Sumiko Hamamoto, et al.Molecular and Cellular Endocrinology|November 24, 2011
Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survivalKoji Nakashima, Masashi Shimoda, Sumiko Hamamoto, et al.The Journal of Nutritional Biochemistry|December 10, 2014
Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic miceYukiko Kanda, Mitsuru Hashiramoto, Masashi Shimoda, et al.American Journal of Physiology. Endocrinology and Metabolism|November 19, 2009
Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonistYukiko Kanda, Masashi Shimoda, Sumiko Hamamoto, et al.Endocrine Journal|August 27, 2009
Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygoteYukiko Kanda, Masashi Shimoda, Kazuhito Tawaramoto, et al.Molecular and Cellular Endocrinology|December 3, 2014
Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetesTomohiko Kimura, Hideaki Kaneto, Masashi Shimoda, et al.Internal Medicine (Tokyo, Japan)|September 2, 2009
Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergyFumiko Kawasaki, Shinji Kamei, Fuminori Tatsumi, et al.Molecular and Cellular Endocrinology|June 28, 2015
Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expressionHidenori Hirukawa, Hideaki Kaneto, Masashi Shimoda, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2015
[The trend of new drug development for the treatment of diabetes mellitus]Kohei KakuPageof 34